Comparison of the effectiveness of Osteomed, Osteomed Forte and Osteo-Vit D3 in the prevention of osteoporotic fractures of various localization

DOI: https://doi.org/10.29296/25877305-2021-10-16
Download full text PDF
Issue: 
10
Year: 
2021

Professor D. Dedov, MD Tver State Medical University Tver Regional Clinical Cardiology
Dispensary

The article discusses the issues of diagnosis, pathogenesis, clinical picture of osteoporosis, as well as the prevention of osteoporotic fractures of various localization using the drugs Osteomed, Osteomed Forte and Osteo-Vit D3. The effectiveness of these drugs in the complex therapy of osteoporosis, increasing bone mineral density, reducing the likelihood of recurrent injuries, and improving the quality of life has been shown.
Keywords: 
osteoporosis
osteoporotic fractures
prevention
Osteomed
Osteomed Forte
Osteo-Vit D3

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. 1. Lubenets A. Lechenie povrezhdenij proksimal'nogo otdela bedrennoj kosti u bol'nyh starshej vozrastnoj gruppy. Vrach. 2017; 7: 65–7 [Lubenets A. Treatment of proximal femur injuries in older age group patients. Vrach. 2017; 7: 65–7 (in Russ.)].
  2. 2. Mjagkova M.A., Skripnikova I.A., Shal'nova S.A. i dr. Assotsiatsii 10-letnej verojatnosti osteoporoznyh perelomov s summarnym serdechno-sosudistym riskom i serdechno-sosudistymi zabolevanijami, obuslovlennymi aterosklerozom, sredi gorodskogo i sel'skogo naselenija. Profilakticheskaja meditsina. 2021; 24 (6): 18–27 [Myagkova M.A., Skripnikova I.A., Shalnova S.A. et al. Associations of the 10-year probability of osteoporotic fractures with the total cardiovascular risk and cardiovascular diseases due to atherosclerosis among urban and rural populations. Profilakticheskaya Meditsina. 2021; 24 (6): 18–27 (in Russ.)]. DOI: 10.17116/profmed20212406118
  3. 3. Mjagkova M.A., Skripnikova I.A., Shal'nova S.A. i dr.. Analiz rasprostranennosti klinicheskih faktorov riska osteoporoznyh perelomov sredi gorodskogo i sel'skogo naselenija RF (po dannym epidemiologicheskogo issledovanija ESSE-RF-2). Profilakticheskaja meditsina. 2020; 23 (6): 60–8 [Myagkova M.A., Skripnikova I.A., Shalnova S.A. et al. Analysis of the prevalence of clinical risk factors of osteoporotic fractures among urban and rural populations of the Russian Federation (according to the epidemiological study ESSE-RF-2). Profilakticheskaya Meditsina. 2020; 23 (6): 60–8 (in Russ.)]. DOI: 10.17116/profmed20202306160
  4. 4. Mel'nichenko G.A., Belaja Zh.E., Rozhinskaja L.Ja. i dr. Federal'nye klinicheskie rekomendatsii po diagnostike, lecheniju i profilaktike osteoporoza. Problemy endokrinologii. 2017; 63 (6): 392–426 [Melnichenko G.A., Belaia Zh.E., Rozhinskaia L.Ia. et al. Russian federal clinical guidelines on the diagnostics, treatment, and prevention of osteoporosis. Problemy Endokrinologii. 2017; 63 (6): 392–426 (in Russ.)]. DOI: 10.14341/probl2017636392-426
  5. 5. Pavlova T., Bashuk I. Kliniko-morfologicheskie osobennosti degenerativnyh izmenenij kostnoj tkani na fone osteoporoza v vozrastnom aspekte. Vrach. 2019; 30 (6): 47–50 [Pavlova T., Bashuk I. Clinical and morphological features of degenerative changes in bone tissue with osteoporosis in age aspects. Vrach. 2019; 30 (6): 47–50 (in Russ.)]. DOI: 10.29296/25877305-2019-06-11.
  6. 6. Peshehonova L.K., Peshehonov D.V., Krasjukov P.A. Klinicheskaja effektivnost' primenenija preparatov Osteomed, Osteomed Forte, Osteo-Vit D3 u bol'nyh vtorichnym osteoporozom pri revmatoidnom artrite. Vrach. 2020; 31 (4): 68–74 [Peshekhonova L., Peshekhonov D., Krasyukov P. The clinical efficiency of using Osteomed, Osteomed Forte, and Osteo-Vit D3 in patients with secondary osteoporosis in rheumatoid arthritis. Vrach. 2020; 31 (4): 68–74 (in Russ.)]. DOI: 10.29296/25877305-2020-04-12.
  7. 7. Skripnikova I.A., Gur'ev A.V., Shal'nova S.A. i dr. Rasprostranennost' klinicheskih faktorov, ispol'zuemyh dlja otsenki riska osteoporoticheskih perelomov. Profilakticheskaja meditsina. 2016; 19 (5): 32–40 [Skripnikova I.A., Gur’ev A.V., Shalnova S.A. et al. The prevalence of clinical factors used for risk assessment of osteoporotic fractures. Profilakticheskaya Meditsina. 2016; 19 (5): 32–40 (in Russ.)]. DOI: 10.17116/profmed201619532-40
  8. 8. Strukov V., Burmistrova L., Elistratov D. i dr. Osteoporoz: diagnostika i effektivnoe lechenie. Vrach. 2014; 4: 52–4 [Strukov V., Burmistrova L., Elistratov D. et al. Osteoporosis: diagnosis and effective treatment. Vrach. 2014; 4: 52–4 (in Russ.)].
  9. 9. Strukov V., Kislov A., Elistratov D. i dr. Personifitsirovannyj podhod v terapii osteoporoza u pozhilyh. Vrach. 2015; 6: 51–3 [Strukov V., Kislov A., Elistratov D. et al. Personified approach in the therapy of osteoporosis in elderly patients. Vrach. 2015; 6: 51–3 (in Russ.)].
  10. 10. Strukov V., Potapov V., Kislov A. i dr. Osteoporoz – problema pozhilyh: smirit'sja ili lechit'sja? Vrach. 2014; 6: 30–2 [Strukov V., Potapov V., Kislov A. et al. Osteoporosis is a problem of the elderly: to accept or to be treated? Vrach. 2014; 6: 30–2 (in Russ.)].